TheraSphere Prostate Cancer Device

· Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TheraSphere Prostate Cancer Device, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device [NA]